Industry Events Calendar

Applications of artificial intelligence in health care are expanding rapidly. Despite its great long-term potential, risks and challenges remain for both AI developers and their partners in health care, the life sciences industry and digital health.

This Harvard Medical School Executive Education program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as real-world implementation, with examples drawn from health care delivery/operations and drug development.

The curriculum will feature a combination of live virtual class sessions, small group application exercises, pre-work and vigorous discussions. Upon completion of the program, participants will be able to immediately apply insights gained to the fast-moving and complex health care sector. A certificate of completion will be provided.

Learn More

The 12th Annual World Bispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique discovery, translational, and manufacturing challenges faced in the bispecific field. Whatever your role and interest, you will leave the meeting with concrete methods to employ into your strategy and pipeline to convert the promise of bispecific therapeutics into a reality for patients.

Discover who the 50+ expert speakers are, and the topics they will examine, including how:

– OSE Immunotherapeutics is pioneering their unique platform BiCKI a bispecific platform optimized for the development and manufacturing of bispecific cytokine fusion proteins
– GT Biopharma and Light Chain Bioscience are showcasing the next generation of innate cell engagers for the treatment of solid tumors
– Merus, Pfizer, and Innate Pharma are expanding the boundaries of biotherapeutics with tri-specific and multi-specific antibodies
– Genentech, Pfizer, and City of Hope are discussing approaches to reduce on-target off-tumor toxicities including dosing strategies in liquid and solid tumor indications
– Xencor, Harbour Biomed, and Harpoon Therapeutics will discuss their unique platforms and CMC strategies for scale-up and production
– IGM Biosciences and MacroGenics will evaluate biomarker strategies for bispecific candidates during clinical development

Register now

Demy-Colton, a leader in connecting life science and digital health executives, announced today the speaker list and updated panel sessions for BioFuture, a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies to “Reimagine the Future of Healthcare”. BioFuture will be held in New York City on October 5-6, 2021, at Cure, Deerfield’s vertical healthcare-dedicated innovation campus, with a virtual attendance option.

The opening plenary, “Rethinking Healthcare in a Post-Pandemic World” features moderator Sara Jane Demy, Founder & CEO, Demy-Colton, with esteemed panelists Ralph Snyderman and James E. Flynn, Managing Partner, Deerfield.

The event will also feature Rick Bright, PhD, Senior Vice President, Pandemic Prevention & Response, Health Initiative, The Rockefeller Foundation, as he discusses Global Health and Preparing for the Next Pandemic.
On day two of the conference, Adam Gazzaley, MD, PhD, David Dolby Distinguished Professor of Neurology, Physiology & Psychiatry, UC San Francisco, will discuss: “Psychedelics and Virtual Reality: Entering a New era of Experiential Medicine.”

Panels and Dialogues include:
• The Pursuit of Healthiness: Democratizing Access in a Changed World
• The Future of Regenerative Medicine is Personalized
• New Therapies for Alzheimer’s Disease
• Next Gen Oncology Therapeutics that will Change the Cancer Landscape
• Investing in Health & Happiness
• Devices & Robotics
• Manufacturing: Is it Realistic to Think that We can Reduce its Cost?
• Psychedelic Therapies: Improving Mental Health for Patients with Digital Technologies
• Open Mic: Humans vs Machines Round 2
• Venture Capital Trends in Digital Health
• Next Wave Diagnostics: AI and Health Innovations Accelerate Dx
• The New Wave of Disease-Modifying Digital Therapeutics
• Synthetic Biology is the Future of Healthcare
• From Rags to Riches: Will the Trend of Fantastical A-rounds, Oversized IPOs and SPAC Utilization continue in 2022?

Hope to see you all there!

Learn More

The CureSearch Pediatric Early Development Symposium (PEDS) is a collaborative forum to address the unique aspects and challenges of pediatric cancer clinical trial design. Attendees from academia, industry and regulatory agencies will present and discuss current and upcoming issues around designing and conducting clinical trials for limited patient populations. Experts in the field will convene to provide real-world examples and solutions relating to clinical trial design, optimization and conduct.

Learn More

Bringing together healthcare’s brightest innovators and pharma’s decision-makers, Pharma Europe is where we will set the roadmap for a new era of pharma. One where pharma, patients, providers and society are united in their efforts of greater patient value.

Register now

It’s been almost a decade since the release of the first stunning data on a cell therapy that battled blood cancer by genetically altering a patient’s own white blood cells to attack it.

Many years and billions of dollars in mergers and acquisitions later, CAR-T is still used mostly as a last resort. Could new clinical trials that are about to report out in full change that?

STAT’s Adam Feuerstein gathers experts to look ahead.

Register now

You are invited to join Ruth Lehmann, President and Director of the Whitehead Institute, for a series of virtual dialogues with scientific luminaries from academia and visionary leaders from the biotech industry.

What trends in science and technology excite them the most? Which innovations have the potential to dramatically impact the way we live and work?
Be a part of the conversation.

Register now

In this Harvard Medical School Executive Education live virtual webinar, Sekar Kathiresan, MD will discuss his journey from being a professor and cardiologist at Harvard Medical School to becoming the co-founder and chief executive officer of Verve Therapeutics. He will discuss leading Verve through its promising preclinical studies, its recent IPO and the road ahead – and the scientific and leadership lessons learned.

Learn More